Blastic transformation of p53-deficient bone marrow cells by p210(bcr/abl) tyrosine kinase

Blastic transformation of chronic myelogenous leukemia (CML) is characterized by the presence of nonrandom, secondary genetic abnormalities in the majority of Philadelphia(1) clones, and loss of p53 tumor suppressor gene function is a consistent finding in 25–30% of CML blast crisis patients. To tes...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Skorski, Tomasz, Nieborowska-Skorska, Malgorzata, Wlodarski, Pawel, Perrotti, Danilo, Martinez, Robert, Wasik, Mariusz A., Calabretta, Bruno
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1996
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC24059/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8917557/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.23.13137
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!